Introduction
Neuroblastoma (NBL) is one of the most common pediatric solid tumors and is derived from the sympathoadrenal lineage of the neural crest. The tumors found in patients under the age of 1 year are usually favorable and often show spontaneous dierentiation and regression (Nakagawara, 1998a) . Although the molecular mechanism underlying the NBL regression is still unclear, there are accumulating evidences to suggest that cell death regulatory molecules including Bcl-2 and caspases play an important role in the NBL regression (Hoehner et al., 1997; Nakagawara et al., 1997) .
Our previous studies have shown that expression of caspase-1 and caspase-3 is increased in favorable stage NBLs, while it is low in advanced stage tumors. Both caspases appear to be localized in the nuclei of the NBL cells undergoing regression (Nakagawara et al., 1997) . Those results have suggested that at least a part of the caspase cascade is activated in vivo in the NBLs with favorable prognosis. Then, if activation of caspases plays a role in regulating programmed cell death of NBLs, the IAP family molecules which inhibit the activity of some caspases by direct interaction could also be functioning in NBLs. In addition, gain of the chromosome 17q distal region has recently been implicated in close correlation with aggressiveness of neuroblastoma (Caron, 1995; Plantaz et al., 1997; Brown et al., 1999) . The region has been narrowed down to 17q21-qter which should include the SVV gene (Plantaz et al., 1997) . At variance with Bcl-2 (Reed, 1994; Yang et al., 1996) or other IAPs, expression of SVV is developmentally regulated (Adida et al., 1998a; Barinaga, 1998) . It is strongly downregulated and undetectable in normal adult tissues but is prominently expressed in most human cancers (Ambrosini et al., 1997; Lu et al., 1998) . In addition, it is intriguing that expression of SVV becomes restricted to neural crest-derived cells including dorsal root ganglion neurons in mouse embryo at embryonic day 15 to postnatal day 21 (Adida et al., 1998a) . Recent study has also demonstrated that targeting of the SVV gene induces apoptosis as well as inhibition of cell proliferation . These have stimulated us to examine the role of SVV in NBL.
In this study, we have found that the levels of SVV mRNA are high in both advanced stage NBLs and NBL cell lines, and its high expression is signi®cantly associated with poor prognostic factors. In NBL cell lines, induction of apoptosis has been associated with remarkable down-regulation of the SVV expression.
Results

Expression of Survivin in primary neuroblastomas and cell lines
primary NBLs as well as NBL cell lines (Figure 1) . Figure 1a shows a representative of the Northern blot analysis for SVV expression in primary NBLs. As shown in Figure 2 , when normalized to the b-actin expression, the levels of SVV expression were higher in advanced stages than in lower stages: 10.3+4.3 (arbitrary density units, mean+standard error, n=11) in stage 1; 33.7+30.6 (n=6) in stage 2; 9.8+7.8 (n=2) in stage 4s; 58.6+28.6 (n=8) in stage 3; and 114+55.7 (n=7) in stage 4. There was no signi®cant dierences in expression of SVV between tumors found by mass screening and sporadic tumors in early stages (data not shown). Since the levels of SVV mRNA in some favorable tumors were almost undetectable, we performed Southern blot analysis to examine if there was deletion of the SVV gene in those tumor DNA. However, we found no deletion of the gene in the tumor samples tested (data not shown). SVV mRNA was expressed in most of neuroblastoma cell lines and the levels of expression were higher in NBL cell lines than those in adult cancer cell lines such as colorectal, breast and lung cancers (Figure 1b) .
Correlation between Survivin mRNA expression and clinical or biological prognostic factors
To evaluate the signi®cance of SVV mRNA expression in primary NBLs, we statistically analysed its correlation with age at diagnosis, disease stage, mass screening TrkA mRNA expression, DNA ploidy and MYCN ampli®cation (Table 1) . There was strongly signi®cant correlation between high levels of SVV expression and over 1 year of age (two sample t-test; P=0.0003), advanced stages (P=0.0136), sporadic tumors (P=0.0027) or low levels of TrkA expression (P=0.0030). Both DNA diploidy and MYCN ampli®cation also showed a tendency to be associated with high levels of SVV expression. Thus, the SVV expression at high levels appeared to be correlated with other poor prognostic indicators so far known. 
Changes in Survivin expression during apoptosis and differentiation of neuroblastoma cells
We next tested if expression of SVV is changed in the dierent biological conditions of neuroblastoma cells in vitro. As a cell death model, CHP134 and IMR32 neuroblastoma cell lines were chosen because both cells underwent apoptosis after treatment with 5 mM RA or serum deprivation for 4 ± 5 days ( Figure 3 ). Expression of SVV was strongly down-regulated in both cell lines during the apoptosis triggered by the RA treatment or serum starvation (Figure 4a ). The apoptosis was con®rmed by TUNEL staining (Figure 3a ,b for CHP134 cells). Expression of Bcl-2 was not changed in the same system (data not shown). Next, as a model of neuroblastoma dierentiation, we used SH-SY5Y and CHP901 cells which showed dierentiation by extending neurites after treatment with 5 mM RA without dying for at least 10 days ( Figure 3c ,d for SH-SY5Y cells). The RA-induced dierentiation of both NBL lines caused moderate decrease of SVV mRNA expression which was maintained for at least 5 days (Figure 4b ; left). However, when the cells were treated in the serum-free medium, they died by accompanying with the strong down-regulation of SVV expression (Figure 4b ; right). Finally, as a model refractory to apoptosis or dierentiation, we used SK-N-AS cells which neither respond to RA nor die after serum deprivation for at least 8 days (Figure 3e,f). As shown in Figure 4c , levels of SVV transcript were unchanged or rather increased.
Induction and activation of caspase-3 during apoptosis of CHP134 cells
One of the target molecules of SVV is caspase-3 which in turn cleaves DFF45/ICAD, an inhibitor of DNA fragmentation factor (DNA endonuclease), during the apoptotic process. In conjunction with down-regulation of SVV, the caspase-3 protein was induced ( Figure 5a) and activated in the CHP134 cells treated with RA, which was shown by the stimulated cleavage of the DFF45/ICAD protein (Figure 5b ). The PARP protein, another target molecule of caspase-3, was also cleaved in the same apoptotic system (data not shown).
Transfection of Survivin inhibits apoptosis in CHP134 cells treated with retinoic acid
To test if SVV could inhibit apoptosis in NBL, we transfected CHP134 cells with full-length SVV cDNA or the vector alone. The results showed that most of the cells transfected with SVV did not die and extended numerous neurites for at least 10 days after the treatment with 5 mM RA, while the cells transfected with the vector alone died similarly to the control cells within 6 days of RA treatment ( Figure 6 ). In this condition, the activation of caspase-3 was inhibited in the SVV-transfected cells (data not shown).
Presence of the Survivin signal in the gained chromosome 17q with a t(1;17) translocation in a primary neuroblastoma with MYCN amplification
To con®rm the presence of the SVV signal in the 17q gain, we performed a FISH analysis. The SVV PAC clone was probed for the metaphase and interphase nuclei obtained from the fresh tumor specimen of the patient (case No. 342) with stage 3 NBL whose MYCN gene was ampli®ed (4100 copies). The NBL cells had one normal chromosome 1 with both the D1Z1 and D1Z2 signals, and one 1p-chromosome with only the D1Z1 signal. The tumor cells also had two normal chromosomes 17 with both the cCI17-321 and SVV signals, and one derivative chromosome consisting of most chromosome 1 and 17q with the SVV signal (data not shown). These suggested that, in this tumor, the distal region of 17q containing the SVV gene locus was gained and translocated to the chromosome 1p whose distal region was deleted. 
Discussion
In the present study, we have demonstrated that SVV is expressed at high levels in many NBL cell lines compared with those in other cancer cell lines. In primary NBLs, which include tumors found by the mass screening, increased levels of SVV mRNA expression show highly signi®cant association with age greater than 12 months at diagnosis, advanced stages, sporadic tumors and low levels of TrkA expression. Both diploidy/tetraploidy of the DNA ploidy pattern and MYCN ampli®cation also have a tendency to be associated with high levels of SVV expression. This suggests that increased expression of SVV is correlated with poor prognosis in patients with NBL, although it has not been statistically proved by the survival curve in the present report because of shortage of the follow-up duration at this time. Furthermore, it is interesting that the expression level of SVV in advanced stage tumors appears not to simply be a gene dosage but a stimulation of the induction. In NBL cell lines, expression of SVV is strongly down-regulated during the induction of apoptosis and slightly decreased as the cells dierentiate. Furthermore, transfection of SVV almost completely protected the NBL cells from dying. Thus, our present data suggest that SVV expression is a poorprognostic indicator in NBL and plays an important role in regulating growth, dierentiation and cell death of NBLs both in vivo and in vitro.
The molecular mechanism of spontaneous regression and dierentiation of NBL is still unclear. However, accumulating evidences suggest that, like normal sympathetic neurons, nerve growth factor (NGF) and its receptor complex, TrkA and p75 NTR , play a role in regulating dierentiation and cell death of NBL (Nakagawara, 1998b; Nakagawara et al., 1993) . Furthermore, the neuronal cell death caused by withdrawal of NGF is at least partly mediated by activation of the cell death-related cysteine proteases, caspases (Nakagawara et al., 1997) . In that context, it is interesting that the low levels of TrkA expression has shown the highly signi®cant correlation with the high levels of SVV expression. High levels of TrkA expression may be necessary for NBL cells to dierentiate and/or undergo apoptosis. In regressing NBLs expressing TrkA, some caspases, including caspase-3, may be induced and also activated. The decreased expression of SVV may enhance the apoptotic process in those favorable NBLs. In contrast, in advanced stage tumors, high levels of SVV expression tend to be associated with DNA diploidy as well as MYCN ampli®cation, both of which are typical indicators of aggressive NBL. Thus, it is possible that SVV is acting to promote survival of a b c Figure 4 Changes in expression of Survivin mRNA during dierentiation and apoptosis of neuroblastoma cell lines. Three neuroblastoma cell lines (CHP134, SH-SY5Y, and SK-N-AS) were treated with 5 mM all-trans retinoic acid (RA) or were cultured in the serum-free RPMI1640 medium for 5 ± 7 days at 378C in 5% CO 2 -air. (a) CHP134 cells underwent moderate morphological dierentiation followed by apoptosis by day 5 ± 7 after starting to treat with RA (a; left) or serum deprivation (a; right). Apoptosis induced by either treatment was accompanied by complete down-regulation of SVV expression. (b) SH-SY5Y cells were induced to extend neurites and survived at least for 7 days after treating with RA, under which condition the SVV expression decreased but maintained at low levels at least by day 5 (b; left). On the other hand, the serum deprivation caused apoptosis of SH-SY5Y cells by day 3 ± 5, which accompanied by complete down-regulation of SVV expression (b; right). (c) SK-N-AS cells were refractory to RA or serum starvation, and levels of SVV mRNA were maintained during the days indicated such NBL cells. High levels of SVV expression at the protein level in advanced stages of NBL has also been shown (Adida et al., 1998b) .
In support of the above hypothesis, our present in vitro data have demonstrated that SVV is expressed in many NBL cell lines at signi®cantly high levels and downregulated during the apoptosis. Expression of SVV mRNA has also found to be slightly decreased during the dierentiation of NBL cell lines. In contrast, proliferating NBL cells express steady or even increased levels of SVV mRNA. Those observations may be consistent with the recent evidence that SVV expression is dependent on the cell cycle and prevents undue apoptosis by stabilizing mitotic spindle (Li et al., 1998) .
Thus, based on accumulating evidences including our present data, we hypothesize that, in favorable NBLs, the de®cient signals from TrkA receptor might induce and activate caspase-3, which in turn inactivates DFF45/ICAD. The degradation of DFF45/ICAD then activates DFF40/CAD endonuclease which causes DNA fragmentation and leads the cells to apoptotic death. During the process, expression of SVV is downregulated, that might further enhance the cell death. On the other hand, in aggressive NBL, expression of both TrkA and caspase-3 is down-regulated, while expression of SVV is up-regulated. Such tumor cells might be able to continue to grow by inhibiting apoptosis.
The SVV gene is mapped to chromosome 17q25 (Ambrosini et al., 1997) . Recent advances of the comparative genomic hybridization studies have revealed that the gain of the distal region of chromosome 17q which possibly includes the SVV locus is signi®cantly associated with poor clinical outcome (Plantaz et al., 1997; Lastowska et al., 1997) .
Our present FISH analysis have ®rst shown a direct evidence that the SVV gene is involved in the 17q gain which is translocated to the distal region of 1p with terminal deletion in the MYCN-ampli®ed tumor. Thus, the present data suggest that SVV could be one of the candidate genes for the gain of 17q distal region in NBL. The analysis for searching the relationship between the copy number of the SVV gene and its expression levels in primary NBLs is being underway. Whether or not the SVV gene is mutated in some NBLs may also need to be pursued. Thus, the intracellular SVV which is highly expressed in aggressive NBLs could be a novel target for the future therapeutic strategy.
Materials and methods
Patients
We studied tumors from 34 Japanese children with neuroblastomas which were diagnosed between February, 1996 and August, 1998. Twenty patients were identi®ed by mass screening at the age of 6 months. The selection of tumors for study was based solely on the availability of a sucient amount of tumor tissue from which to prepare DNA and messenger RNA (mRNA) for the analyses described below.
All diagnoses of neuroblastoma were con®rmed by histologic assessment of a tumor specimen obtained at surgery. The histologic features of the tumors were classi®ed according to the Shimada's classi®cation (Shimada et al., 1984) . There were 23 tumors with favorable histology, ten with unfavorable histology, and one without examination. The tumors were staged according to the International Neuroblastoma Staging System (INSS) . Eleven patients had stage 1 tumors, six had stage 2 tumors, two had stage 4s tumors, eight had stage 3 tumors, and seven had stage 4 tumors. Patients were treated according to previously described protocols (Kaneko et al., 1998) .
Tumor tissues and cell lines
Fresh NBL tissues were obtained at surgery and stored at 7808C, as described previously (Nakagawara et al., 1997) . Human cell lines which we used were NBL cell lines (CHP134, IMR32, SH-SY5Y, CHP901, and SK-N-AS), the colon cancer cell line (Caco-2), the breast cancer cell line (MOA-MB-453) and the lung cancer cell line (A549).
Cell culture
Cells were cultured at 378C in a 5% CO 2 atmosphere using RPMI1640 (Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies, GIBCO ± BRL, USA) and 100 mg/ml gentamycin. All-trans retinoic acid (RA, Sigma Chemicals, Saint Louis, MO, USA) was dissolved in pure ethanol at a concentration of 5 mM and stored at 7808C. For the experiment to induce apoptosis, cells were plated on 60-mm diameter dishes and were grown to 20 ± 25% con¯uence. Then, RA (5 mM at ®nal concentration) was added to the culture, or the medium was changed to the serum-free condition. Cells were harvested every alternate day and total RNA was extracted using TRIZOL reagent (Life Technologies, GIBCO ± BRL, USA).
Survivin cDNA synthesis A full-length SVV cDNA was synthesized by reverse transcriptase reaction using total RNA prepared from CHP134 cells and the SVV-speci®c oligonucleotide primer (5'-GACGTCCAAGGAATAGACAG-3'). The reaction product was ampli®ed by a primer pair, 5'-CCAGATTT-GAATCGCGGGAC-3' and 5'-GACAGATAAGGAACCT-GCAG-3' (936 bp product including a full open reading frame), and subcloned into the plasmid vector (pGEM-T Easy, Promega, Madison, WI, USA) with subsequent DNA sequencing for con®rmation.
Northern analysis
Total RNA from the primary tumors or cultured cells was prepared according to the method of Chomczynski and Sacchi (1987) . Twenty mg of total RNA were run on a 1.5% denaturing agarose gel and transferred to a Hybond-N + membrane (Amersham Life Sciences, Arlington Heights, IL, USA). The SVV-speci®c single strand probe was generated by the asymmetric PCR ampli®cation of the 0.6 mg SVV cDNA with 0.4 mM oligonucleotide primer (5'-GCACTTTCTTCG-CAGTTTCC-3'), 20 pmol dNTP, 180 pmol dCTP, 100 mCi [ 32 P]dCTP and 2.5 U of Taq DNA polymerase (Toyobo, Tokyo, Japan) in a 10 ml reaction mixture. The SVV mRNA expression was normalized by expression of b-actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The values of expression levels of SVV were shown as arbitrary density units.
Western blot analysis
CHP134 cells were treated with 5 mM retinoic acid and harvested at indicated times. The cells were lysed in a buer containing 25 mM Tris-HCl (pH 8.0), 137 mM NaCl, 3 mM KCl, 10 mg/ml leupeptin, 5 mg/ml aprotinin, 1 mM sodium azide, 1 mM phenylmethylsulfonyl¯uoride (PMSF) and 1% NP-40. Western blot analysis was performed as reported previously (Nakagawara et al., 1997) . After transferring to an Immobilon-P membrane (Millipore, Bedford, MA, USA), proteins of caspase-3, DFF45/ICAD and poly-ADP ribose polymerase (PARP) were reacted with either a monoclonal anti-caspase-3 antibody (Transduction Laboratories, Lexington, KY, USA), a polyclonal anti-DFF45/ICAD antibody (Santa Cruz Biotechnology, Inc., CA, USA) or a monoclonal anti-PARP antibody (BIOMOL, Plymouth Meeting, PA, USA), respectively. The protein was detected by the alkaline phosphatase kit (Promega, Madison, WI, USA).
TUNEL staining
Cells were harvested and centrifuged at 800 g for 5 min at 48C. The cell pellet was ®xed in 10% formalin overnight, dehydrated, and embedded in paran blocks. The sections of 3 ± 5 mm in thickness were put on high adhesive slides (Matsunami Glass Indust., Co. Ltd., Japan) and subjected to TUNEL staining as reported previously (Nakagawara et al., 1997) .
Stable transfection of survivin into CHP134 cells
A SVV construct for transfection was generated by subcloning the 936 nt SVV cDNA at EcoRI site in the pcDNA3 mammalian expression vector (Invitrogen, San Diego, CA, USA). CHP134 cells cultured in 6 cm diameter tissue culture plates were transfected with 10 mg of the SVV cDNA construct or the vector alone using LipofectAMINE (Life Technologies, Inc.). Cells were selected in the medium containing 400 mg/ml geneticin (Sigma). The clones stably expressing SVV were con®rmed by Northern analysis.
PAC screening and FISH analysis
PAC clones containing the SVV gene were isolated by PCRbased three-dimensional screening of the RPCI human PAC library (Ioannou et al., 1994) and used as FISH probes.
FISH experiments were carried out on the ®xed samples used for chromosome analysis. To detect the copy number of chromosome 1 and presence or absence of 1p deletion, we used repetitive DNA probes, D1Z1 (pUC1.77) and D1Z2 (p1 ± 79), speci®c for the pericentromeric region (1q12) and the subtelomeric region (1p36.33), respectively (Christiansen et al., 1992) . D1Z1 was labeled with digoxigenin (dig)-11-dUTP, and D1Z2 with biotin (bio)-16-dUTP (Boehringer Mannheim) by nick translation. To detect the copy number of chromosome 17 and gains of chromosome arm 17q, we used a centromeric probe (cCI17-321) (Inazawa et al., 1993) and a PAC clone including the SVV gene. cCI17-321 was labeled with dig-11-dUTP, and the PAC clone with bio-16-dUTP by nick translation. Chromosomes were stained with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI). Twocolor FISH was performed as previously described (Kobayashi et al., 1996) .
Statistical analysis
Since the distribution of SVV expression was skewed, the log transformation was employed to achieve the normality. A two sample t-test was used to compare between the SVV expression and clinical or biological variables. 
